Role of antiplatelet agents in stroke.
DuPont Pharmaceuticals Co, Experimental Station E400/3470, Wilmington, DE 19880-0400, USA. shaker.a.mousa@dupontpharma.com
S A
SA
Mousa
D000818:Animals; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D019039:Platelet Glycoprotein GPIIb-IIIa Complex / Q000037:antagonists & inhibitors; D020521:Stroke / Q000150:complications / Q000188:drug therapy*
D005343:Fibrinolytic Agents; D010975:Platelet Aggregation Inhibitors; D019039:Platelet Glycoprotein GPIIb-IIIa Complex